Dr. Mehmet Oz, the celebrity physician nominated by President Donald Trump to oversee the government's Medicare and Medicaid health plans, appears to have underpaid his own Medicare taxes by over $400 ...
Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.
President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and ...
Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.
Christopher Ridley, a spokesperson for Moderna, said the state legislative efforts are largely a product of ...
New trial data showed the drug helped obese or overweight type 2 diabetics lose an average 15.7% of their weight, when an ...
Health-care companies fell as traders retreated from some of the highest risk issues.
4d
MarketBeat on MSNDespite Challenges Novo Nordisk Plans to Crush GLP-1 CompetitorsNovo Nordisk A/S (NYSE: NVO) has declared that its GLP-1 drugs for chronic obesity, under the brands Ozempic and Wegovy, are ...
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.
Most HHS workers were emailed an offer to leave their job for as much as $25,000 as part of President Trump’s government cuts ...
Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results